Lung cancer

137 A Randomised Controlled Feasibility Trial of Surgery versus No Surgery as Part of Multi-Modality Treatment in Stage III – N2 Non-Small Cell Lung Cancer

Pub Date : 2024-04-01 DOI: 10.1016/j.lungcan.2024.107698 Sally Taylor, Melissa Stanworth, Ashleigh Ward, Emily Harris, S. Tsim, Neal Navani, David Baldwin, Ian Woolhouse, John Edwards, Seamus Grundy, Sarah Rhodes, Nathan Burnside, Fiona H Blackhall, Corinne Faivre-Finn, Janelle Yorke, M. Evison

101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic

Pub Date : 2024-04-01 DOI: 10.1016/j.lungcan.2024.107662 F. Gomes, N. Gilding, V. Tan, K. Christoforou, J. Rule, A. Aziez, Adam Januszewski, A. Minchom

122 Social Isolation and Lung Cancer: Does This Impact the Length of Time on The Lung Cancer Pathway Or Uptake Of MDT Recommended Treatments

Pub Date : 2024-04-01 DOI: 10.1016/j.lungcan.2024.107683 Victoria Anderson, Pamela Dalrymple, Gemma Crowley, Paula Shephard, Chole Holmes, Julia McAdams, June Morley, Elliot Sarah, Sarah Ivey, Kate Bentley, George Bate, Paul English, Georgina Russell, Layla Bostock